Concepedia
Statistics
Publications
13
Citations
405
H-Index
12
Active since
2018
Affiliations
McGill University(Current)
University of Massachusetts Chan Medical School
Southern Illinois University Carbondale
Leiden University Medical Center
Ionis Pharmaceuticals (United States)
Daniel O’Reilly is an author at McGill University specializing in molecular biology, life sciences, and rna interference.
Publications per year
2018–2025
Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity
Daniel O’Reilly, Zachary J. Kartje, Eman A. Ageely et al. · Nucleic Acids Research · 2018 · 64 citations · Full text
Life Sciences, Biotechnology, Molecular Biology +17
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease
Daniel O’Reilly, Jillian Belgrad, Chantal Ferguson et al. · Molecular Therapy · 2023 · 54 citations · Full text
Life Sciences, Genetics, Molecular Genetics +17
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection
Vignesh Hariharan, Minwook Shin, Ching‐Wen Chang et al. · Proceedings of the National Academy of Sciences · 2023 · 48 citations · Full text
Pharmacy, Medicinal Chemistry, Molecular Medicine +17
Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded Repeat
Liande Li, Xiulong Shen, Zhongtian Liu et al. · Nucleic Acid Therapeutics · 2018 · 44 citations · Full text
Life Sciences, Medicinal Chemistry, Molecular Biology +11
Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles
Eman A. Ageely, Ramadevi Chilamkurthy, Sunit Kumar Jana et al. · Nature Communications · 2021 · 35 citations · Full text
1–5 of 13